Exploring the use of the GLIM criteria to diagnose malnutrition in cancer inpatients

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
NUTRITION, v.116, article ID 112195, 5p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: The Global Leadership Initiative on Malnutrition (GLIM) criteria establish a diagnosis of malnutrition based on the presence of at least one phenotypic and one etiologic criterion. This study aimed to assess the concurrent and predictive validity of the GLIM criteria in hospitalized cancer patients.Methods: This is an observational retrospective study, including 885 cancer patients, ages >18 y, admitted to a medical oncology inpatient unit between 2019 and 2020. All patients at risk for malnutrition according to the Nutritional Risk Screening 2002 score were assessed by the subjective global assessment (SGA) and 14 different combinations of the GLIM criteria. The SGA was considered the gold standard for assessing the con-current validity of the GLIM combinations. For a subsample of patients with data available on inflammatory markers (n = 198), the serum albumin and C-reactive protein were included in the combinations as etiologic criteria. The predictive validity of the different combinations was tested using the occurrence of surgical complications as the clinical outcome. The sensitivity and specificity values were calculated to assess the con-current validity, univariate and multivariate logistic regression models were used to test predictive validity. Adequate concurrent and predictive validity were determined as sensitivity and specificity values >80% and odds ratio values >2.0, respectively.Results: The median age of the patients was 61.0 y (interquartile range = 51.0-70.0). Head and neck cancer was the prevailing diagnosis and 375 patients were at nutritional risk. According to the SGA, 173 (26.1%) patients were malnourished (SGA categories B or C) and the prevalence of malnutrition ranged from 3.9% to 30.0%, according to the GLIM combinations. None of the tested combinations reached adequate concurrent validity; however, the presence of malnutrition according to four combinations independently predicted surgical complications.Conclusions: The predictive validity of the GLIM was satisfactory in surgical cancer patients.
Palavras-chave
GLIM, Malnutrition, Oncology, Subjective global assessment, C -reactive protein, Serum albumin
Referências
  1. Arends J, 2017, CLIN NUTR, V36, P1187, DOI 10.1016/j.clnu.2017.06.017
  2. Arends J, 2017, CLIN NUTR, V36, P11, DOI 10.1016/j.clnu.2016.07.015
  3. Borges RB, 2021, Clin Biomed Res, V40, P247, DOI [10.22491/2357-9730.109542, DOI 10.22491/2357-9730.109542]
  4. Cederholm T, 2019, CLIN NUTR, V38, P1480, DOI [10.1002/jcsm.12383, 10.1016/j.clnu.2019.02.033, 10.1016/j.clnu.2018.08.002]
  5. Correia MITD, 2022, CLIN NUTR, V41, P687, DOI 10.1016/j.clnu.2022.01.018
  6. Correia MITD, 2017, CLIN NUTR, V36, P958, DOI 10.1016/j.clnu.2016.06.025
  7. Correia MITD, 2003, CLIN NUTR, V22, P235, DOI 10.1016/S0261-5614(02)00215-7
  8. Einarsson S, 2020, CLIN NUTR ESPEN, V37, P100, DOI 10.1016/j.clnesp.2020.03.011
  9. Henrique JR, 2020, NUTRITION, V79-80, DOI 10.1016/j.nut.2020.110961
  10. Huang DD, 2021, CLIN NUTR, V40, P4201, DOI 10.1016/j.clnu.2021.01.038
  11. Kiss N, 2022, CLIN NUTR, V41, P1102, DOI 10.1016/j.clnu.2022.03.024
  12. Liu CY, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.774636
  13. Ryan AM, 2016, P NUTR SOC, V75, P199, DOI 10.1017/S002966511500419X
  14. Sierra JC, 2020, Rev Col Bras Cir, V47, P1
  15. Steer B, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113493
  16. Tan SJ, 2022, CLIN NUTR, V41, P599, DOI 10.1016/j.clnu.2022.01.010
  17. Xu LB, 2022, JPEN-PARENTER ENTER, V46, P385, DOI 10.1002/jpen.2127
  18. Zhang X, 2021, CLIN NUTR, V40, P1224, DOI 10.1016/j.clnu.2020.08.004
  19. Zhang ZH, 2022, CLIN NUTR, V41, P855, DOI 10.1016/j.clnu.2022.02.011